OTC Drug-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data
Report Summary
OTC Drug-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on OTC Drug industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of OTC Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of OTC Drug worldwide and market share by regions, with company and product introduction, position in the OTC Drug market
Market status and development trend of OTC Drug by types and applications
Cost and profit status of OTC Drug, and marketing status
Market growth drivers and challenges
The report segments the global OTC Drug market as:
Global OTC Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global OTC Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Class A
Class B
Global OTC Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Household
Global OTC Drug Market: Manufacturers Segment Analysis (Company and Product introduction, OTC Drug Sales Volume, Revenue, Price and Gross Margin):
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
OTC Drug-Global Market Status & Trend Report 2013-2023 Top 20 Countries Data offers a comprehensive analysis on OTC Drug industry, standing on the readers’ perspective, delivering detailed market data in Global major 20 countries and penetrating insights. No matter the client is industry insider, potential entrant or investor, the report will provides useful data and information. Key questions answered by this report include:
Worldwide and Top 20 Countries Market Size of OTC Drug 2013-2017, and development forecast 2018-2023
Main manufacturers/suppliers of OTC Drug worldwide and market share by regions, with company and product introduction, position in the OTC Drug market
Market status and development trend of OTC Drug by types and applications
Cost and profit status of OTC Drug, and marketing status
Market growth drivers and challenges
The report segments the global OTC Drug market as:
Global OTC Drug Market: Regional Segment Analysis (Regional Production Volume, Consumption Volume, Revenue and Growth Rate 2013-2023):
North America (United States, Canada and Mexico)
Europe (Germany, UK, France, Italy, Russia, Spain and Benelux)
Asia Pacific (China, Japan, India, Southeast Asia and Australia)
Latin America (Brazil, Argentina and Colombia)
Middle East and Africa
Global OTC Drug Market: Type Segment Analysis (Consumption Volume, Average Price, Revenue, Market Share and Trend 2013-2023):
Class A
Class B
Global OTC Drug Market: Application Segment Analysis (Consumption Volume and Market Share 2013-2023; Downstream Customers and Market Analysis)
Hospital
Clinic
Household
Global OTC Drug Market: Manufacturers Segment Analysis (Company and Product introduction, OTC Drug Sales Volume, Revenue, Price and Gross Margin):
Bayer HealthCare
GlaxoSmithKline (GSK)
Johnson&Johnson
Pfizer
Sanofi
AstraZeneca
BioGaia
Bristol Myers Squibb
Bukwang Pharmaceutica
Chr. Hansen
Cipla
CoLucid
Daiichi Sankyo
Friggs
DSM
Eisai
Eli Lilly
Herbalife
Euradite
In a word, the report provides detailed statistics and analysis on the state of the industry; and is a valuable source of guidance and direction for companies and individuals interested in the market.
CHAPTER 1 OVERVIEW OF OTC DRUG
1.1 Definition of OTC Drug in This Report
1.2 Commercial Types of OTC Drug
1.2.1 Class A
1.2.2 Class B
1.3 Downstream Application of OTC Drug
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Household
1.4 Development History of OTC Drug
1.5 Market Status and Trend of OTC Drug 2013-2023
1.5.1 Global OTC Drug Market Status and Trend 2013-2023
1.5.2 Regional OTC Drug Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of OTC Drug 2013-2017
2.2 Sales Market of OTC Drug by Regions
2.2.1 Sales Volume of OTC Drug by Regions
2.2.2 Sales Value of OTC Drug by Regions
2.3 Production Market of OTC Drug by Regions
2.4 Global Market Forecast of OTC Drug 2018-2023
2.4.1 Global Market Forecast of OTC Drug 2018-2023
2.4.2 Market Forecast of OTC Drug by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of OTC Drug by Types
3.2 Sales Value of OTC Drug by Types
3.3 Market Forecast of OTC Drug by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of OTC Drug by Downstream Industry
4.2 Global Market Forecast of OTC Drug by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America OTC Drug Market Status by Countries
5.1.1 North America OTC Drug Sales by Countries (2013-2017)
5.1.2 North America OTC Drug Revenue by Countries (2013-2017)
5.1.3 United States OTC Drug Market Status (2013-2017)
5.1.4 Canada OTC Drug Market Status (2013-2017)
5.1.5 Mexico OTC Drug Market Status (2013-2017)
5.2 North America OTC Drug Market Status by Manufacturers
5.3 North America OTC Drug Market Status by Type (2013-2017)
5.3.1 North America OTC Drug Sales by Type (2013-2017)
5.3.2 North America OTC Drug Revenue by Type (2013-2017)
5.4 North America OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe OTC Drug Market Status by Countries
6.1.1 Europe OTC Drug Sales by Countries (2013-2017)
6.1.2 Europe OTC Drug Revenue by Countries (2013-2017)
6.1.3 Germany OTC Drug Market Status (2013-2017)
6.1.4 UK OTC Drug Market Status (2013-2017)
6.1.5 France OTC Drug Market Status (2013-2017)
6.1.6 Italy OTC Drug Market Status (2013-2017)
6.1.7 Russia OTC Drug Market Status (2013-2017)
6.1.8 Spain OTC Drug Market Status (2013-2017)
6.1.9 Benelux OTC Drug Market Status (2013-2017)
6.2 Europe OTC Drug Market Status by Manufacturers
6.3 Europe OTC Drug Market Status by Type (2013-2017)
6.3.1 Europe OTC Drug Sales by Type (2013-2017)
6.3.2 Europe OTC Drug Revenue by Type (2013-2017)
6.4 Europe OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific OTC Drug Market Status by Countries
7.1.1 Asia Pacific OTC Drug Sales by Countries (2013-2017)
7.1.2 Asia Pacific OTC Drug Revenue by Countries (2013-2017)
7.1.3 China OTC Drug Market Status (2013-2017)
7.1.4 Japan OTC Drug Market Status (2013-2017)
7.1.5 India OTC Drug Market Status (2013-2017)
7.1.6 Southeast Asia OTC Drug Market Status (2013-2017)
7.1.7 Australia OTC Drug Market Status (2013-2017)
7.2 Asia Pacific OTC Drug Market Status by Manufacturers
7.3 Asia Pacific OTC Drug Market Status by Type (2013-2017)
7.3.1 Asia Pacific OTC Drug Sales by Type (2013-2017)
7.3.2 Asia Pacific OTC Drug Revenue by Type (2013-2017)
7.4 Asia Pacific OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America OTC Drug Market Status by Countries
8.1.1 Latin America OTC Drug Sales by Countries (2013-2017)
8.1.2 Latin America OTC Drug Revenue by Countries (2013-2017)
8.1.3 Brazil OTC Drug Market Status (2013-2017)
8.1.4 Argentina OTC Drug Market Status (2013-2017)
8.1.5 Colombia OTC Drug Market Status (2013-2017)
8.2 Latin America OTC Drug Market Status by Manufacturers
8.3 Latin America OTC Drug Market Status by Type (2013-2017)
8.3.1 Latin America OTC Drug Sales by Type (2013-2017)
8.3.2 Latin America OTC Drug Revenue by Type (2013-2017)
8.4 Latin America OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa OTC Drug Market Status by Countries
9.1.1 Middle East and Africa OTC Drug Sales by Countries (2013-2017)
9.1.2 Middle East and Africa OTC Drug Revenue by Countries (2013-2017)
9.1.3 Middle East OTC Drug Market Status (2013-2017)
9.1.4 Africa OTC Drug Market Status (2013-2017)
9.2 Middle East and Africa OTC Drug Market Status by Manufacturers
9.3 Middle East and Africa OTC Drug Market Status by Type (2013-2017)
9.3.1 Middle East and Africa OTC Drug Sales by Type (2013-2017)
9.3.2 Middle East and Africa OTC Drug Revenue by Type (2013-2017)
9.4 Middle East and Africa OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF OTC DRUG
10.1 Global Economy Situation and Trend Overview
10.2 OTC Drug Downstream Industry Situation and Trend Overview
CHAPTER 11 OTC DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of OTC Drug by Major Manufacturers
11.2 Production Value of OTC Drug by Major Manufacturers
11.3 Basic Information of OTC Drug by Major Manufacturers
11.3.1 Headquarters Location and Established Time of OTC Drug Major Manufacturer
11.3.2 Employees and Revenue Level of OTC Drug Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 OTC DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Bayer HealthCare
12.1.1 Company profile
12.1.2 Representative OTC Drug Product
12.1.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bayer HealthCare
12.2 GlaxoSmithKline (GSK)
12.2.1 Company profile
12.2.2 Representative OTC Drug Product
12.2.3 OTC Drug Sales, Revenue, Price and Gross Margin of GlaxoSmithKline (GSK)
12.3 Johnson&Johnson
12.3.1 Company profile
12.3.2 Representative OTC Drug Product
12.3.3 OTC Drug Sales, Revenue, Price and Gross Margin of Johnson&Johnson
12.4 Pfizer
12.4.1 Company profile
12.4.2 Representative OTC Drug Product
12.4.3 OTC Drug Sales, Revenue, Price and Gross Margin of Pfizer
12.5 Sanofi
12.5.1 Company profile
12.5.2 Representative OTC Drug Product
12.5.3 OTC Drug Sales, Revenue, Price and Gross Margin of Sanofi
12.6 AstraZeneca
12.6.1 Company profile
12.6.2 Representative OTC Drug Product
12.6.3 OTC Drug Sales, Revenue, Price and Gross Margin of AstraZeneca
12.7 BioGaia
12.7.1 Company profile
12.7.2 Representative OTC Drug Product
12.7.3 OTC Drug Sales, Revenue, Price and Gross Margin of BioGaia
12.8 Bristol Myers Squibb
12.8.1 Company profile
12.8.2 Representative OTC Drug Product
12.8.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb
12.9 Bukwang Pharmaceutica
12.9.1 Company profile
12.9.2 Representative OTC Drug Product
12.9.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bukwang Pharmaceutica
12.10 Chr. Hansen
12.10.1 Company profile
12.10.2 Representative OTC Drug Product
12.10.3 OTC Drug Sales, Revenue, Price and Gross Margin of Chr. Hansen
12.11 Cipla
12.11.1 Company profile
12.11.2 Representative OTC Drug Product
12.11.3 OTC Drug Sales, Revenue, Price and Gross Margin of Cipla
12.12 CoLucid
12.12.1 Company profile
12.12.2 Representative OTC Drug Product
12.12.3 OTC Drug Sales, Revenue, Price and Gross Margin of CoLucid
12.13 Daiichi Sankyo
12.13.1 Company profile
12.13.2 Representative OTC Drug Product
12.13.3 OTC Drug Sales, Revenue, Price and Gross Margin of Daiichi Sankyo
12.14 Friggs
12.14.1 Company profile
12.14.2 Representative OTC Drug Product
12.14.3 OTC Drug Sales, Revenue, Price and Gross Margin of Friggs
12.15 DSM
12.15.1 Company profile
12.15.2 Representative OTC Drug Product
12.15.3 OTC Drug Sales, Revenue, Price and Gross Margin of DSM
12.16 Eisai
12.17 Eli Lilly
12.18 Herbalife
12.19 Euradite
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OTC DRUG
13.1 Industry Chain of OTC Drug
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF OTC DRUG
14.1 Cost Structure Analysis of OTC Drug
14.2 Raw Materials Cost Analysis of OTC Drug
14.3 Labor Cost Analysis of OTC Drug
14.4 Manufacturing Expenses Analysis of OTC Drug
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
1.1 Definition of OTC Drug in This Report
1.2 Commercial Types of OTC Drug
1.2.1 Class A
1.2.2 Class B
1.3 Downstream Application of OTC Drug
1.3.1 Hospital
1.3.2 Clinic
1.3.3 Household
1.4 Development History of OTC Drug
1.5 Market Status and Trend of OTC Drug 2013-2023
1.5.1 Global OTC Drug Market Status and Trend 2013-2023
1.5.2 Regional OTC Drug Market Status and Trend 2013-2023
CHAPTER 2 GLOBAL MARKET STATUS AND FORECAST BY REGIONS
2.1 Market Development of OTC Drug 2013-2017
2.2 Sales Market of OTC Drug by Regions
2.2.1 Sales Volume of OTC Drug by Regions
2.2.2 Sales Value of OTC Drug by Regions
2.3 Production Market of OTC Drug by Regions
2.4 Global Market Forecast of OTC Drug 2018-2023
2.4.1 Global Market Forecast of OTC Drug 2018-2023
2.4.2 Market Forecast of OTC Drug by Regions 2018-2023
CHAPTER 3 GLOBAL MARKET STATUS AND FORECAST BY TYPES
3.1 Sales Volume of OTC Drug by Types
3.2 Sales Value of OTC Drug by Types
3.3 Market Forecast of OTC Drug by Types
CHAPTER 4 GLOBAL MARKET STATUS AND FORECAST BY DOWNSTREAM INDUSTRY
4.1 Global Sales Volume of OTC Drug by Downstream Industry
4.2 Global Market Forecast of OTC Drug by Downstream Industry
CHAPTER 5 NORTH AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
5.1 North America OTC Drug Market Status by Countries
5.1.1 North America OTC Drug Sales by Countries (2013-2017)
5.1.2 North America OTC Drug Revenue by Countries (2013-2017)
5.1.3 United States OTC Drug Market Status (2013-2017)
5.1.4 Canada OTC Drug Market Status (2013-2017)
5.1.5 Mexico OTC Drug Market Status (2013-2017)
5.2 North America OTC Drug Market Status by Manufacturers
5.3 North America OTC Drug Market Status by Type (2013-2017)
5.3.1 North America OTC Drug Sales by Type (2013-2017)
5.3.2 North America OTC Drug Revenue by Type (2013-2017)
5.4 North America OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 6 EUROPE MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
6.1 Europe OTC Drug Market Status by Countries
6.1.1 Europe OTC Drug Sales by Countries (2013-2017)
6.1.2 Europe OTC Drug Revenue by Countries (2013-2017)
6.1.3 Germany OTC Drug Market Status (2013-2017)
6.1.4 UK OTC Drug Market Status (2013-2017)
6.1.5 France OTC Drug Market Status (2013-2017)
6.1.6 Italy OTC Drug Market Status (2013-2017)
6.1.7 Russia OTC Drug Market Status (2013-2017)
6.1.8 Spain OTC Drug Market Status (2013-2017)
6.1.9 Benelux OTC Drug Market Status (2013-2017)
6.2 Europe OTC Drug Market Status by Manufacturers
6.3 Europe OTC Drug Market Status by Type (2013-2017)
6.3.1 Europe OTC Drug Sales by Type (2013-2017)
6.3.2 Europe OTC Drug Revenue by Type (2013-2017)
6.4 Europe OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 7 ASIA PACIFIC MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
7.1 Asia Pacific OTC Drug Market Status by Countries
7.1.1 Asia Pacific OTC Drug Sales by Countries (2013-2017)
7.1.2 Asia Pacific OTC Drug Revenue by Countries (2013-2017)
7.1.3 China OTC Drug Market Status (2013-2017)
7.1.4 Japan OTC Drug Market Status (2013-2017)
7.1.5 India OTC Drug Market Status (2013-2017)
7.1.6 Southeast Asia OTC Drug Market Status (2013-2017)
7.1.7 Australia OTC Drug Market Status (2013-2017)
7.2 Asia Pacific OTC Drug Market Status by Manufacturers
7.3 Asia Pacific OTC Drug Market Status by Type (2013-2017)
7.3.1 Asia Pacific OTC Drug Sales by Type (2013-2017)
7.3.2 Asia Pacific OTC Drug Revenue by Type (2013-2017)
7.4 Asia Pacific OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 8 LATIN AMERICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
8.1 Latin America OTC Drug Market Status by Countries
8.1.1 Latin America OTC Drug Sales by Countries (2013-2017)
8.1.2 Latin America OTC Drug Revenue by Countries (2013-2017)
8.1.3 Brazil OTC Drug Market Status (2013-2017)
8.1.4 Argentina OTC Drug Market Status (2013-2017)
8.1.5 Colombia OTC Drug Market Status (2013-2017)
8.2 Latin America OTC Drug Market Status by Manufacturers
8.3 Latin America OTC Drug Market Status by Type (2013-2017)
8.3.1 Latin America OTC Drug Sales by Type (2013-2017)
8.3.2 Latin America OTC Drug Revenue by Type (2013-2017)
8.4 Latin America OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 9 MIDDLE EAST AND AFRICA MARKET STATUS BY COUNTRIES, TYPE, MANUFACTURERS AND DOWNSTREAM INDUSTRY
9.1 Middle East and Africa OTC Drug Market Status by Countries
9.1.1 Middle East and Africa OTC Drug Sales by Countries (2013-2017)
9.1.2 Middle East and Africa OTC Drug Revenue by Countries (2013-2017)
9.1.3 Middle East OTC Drug Market Status (2013-2017)
9.1.4 Africa OTC Drug Market Status (2013-2017)
9.2 Middle East and Africa OTC Drug Market Status by Manufacturers
9.3 Middle East and Africa OTC Drug Market Status by Type (2013-2017)
9.3.1 Middle East and Africa OTC Drug Sales by Type (2013-2017)
9.3.2 Middle East and Africa OTC Drug Revenue by Type (2013-2017)
9.4 Middle East and Africa OTC Drug Market Status by Downstream Industry (2013-2017)
CHAPTER 10 MARKET DRIVING FACTOR ANALYSIS OF OTC DRUG
10.1 Global Economy Situation and Trend Overview
10.2 OTC Drug Downstream Industry Situation and Trend Overview
CHAPTER 11 OTC DRUG MARKET COMPETITION STATUS BY MAJOR MANUFACTURERS
11.1 Production Volume of OTC Drug by Major Manufacturers
11.2 Production Value of OTC Drug by Major Manufacturers
11.3 Basic Information of OTC Drug by Major Manufacturers
11.3.1 Headquarters Location and Established Time of OTC Drug Major Manufacturer
11.3.2 Employees and Revenue Level of OTC Drug Major Manufacturer
11.4 Market Competition News and Trend
11.4.1 Merger, Consolidation or Acquisition News
11.4.2 Investment or Disinvestment News
11.4.3 New Product Development and Launch
CHAPTER 12 OTC DRUG MAJOR MANUFACTURERS INTRODUCTION AND MARKET DATA
12.1 Bayer HealthCare
12.1.1 Company profile
12.1.2 Representative OTC Drug Product
12.1.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bayer HealthCare
12.2 GlaxoSmithKline (GSK)
12.2.1 Company profile
12.2.2 Representative OTC Drug Product
12.2.3 OTC Drug Sales, Revenue, Price and Gross Margin of GlaxoSmithKline (GSK)
12.3 Johnson&Johnson
12.3.1 Company profile
12.3.2 Representative OTC Drug Product
12.3.3 OTC Drug Sales, Revenue, Price and Gross Margin of Johnson&Johnson
12.4 Pfizer
12.4.1 Company profile
12.4.2 Representative OTC Drug Product
12.4.3 OTC Drug Sales, Revenue, Price and Gross Margin of Pfizer
12.5 Sanofi
12.5.1 Company profile
12.5.2 Representative OTC Drug Product
12.5.3 OTC Drug Sales, Revenue, Price and Gross Margin of Sanofi
12.6 AstraZeneca
12.6.1 Company profile
12.6.2 Representative OTC Drug Product
12.6.3 OTC Drug Sales, Revenue, Price and Gross Margin of AstraZeneca
12.7 BioGaia
12.7.1 Company profile
12.7.2 Representative OTC Drug Product
12.7.3 OTC Drug Sales, Revenue, Price and Gross Margin of BioGaia
12.8 Bristol Myers Squibb
12.8.1 Company profile
12.8.2 Representative OTC Drug Product
12.8.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bristol Myers Squibb
12.9 Bukwang Pharmaceutica
12.9.1 Company profile
12.9.2 Representative OTC Drug Product
12.9.3 OTC Drug Sales, Revenue, Price and Gross Margin of Bukwang Pharmaceutica
12.10 Chr. Hansen
12.10.1 Company profile
12.10.2 Representative OTC Drug Product
12.10.3 OTC Drug Sales, Revenue, Price and Gross Margin of Chr. Hansen
12.11 Cipla
12.11.1 Company profile
12.11.2 Representative OTC Drug Product
12.11.3 OTC Drug Sales, Revenue, Price and Gross Margin of Cipla
12.12 CoLucid
12.12.1 Company profile
12.12.2 Representative OTC Drug Product
12.12.3 OTC Drug Sales, Revenue, Price and Gross Margin of CoLucid
12.13 Daiichi Sankyo
12.13.1 Company profile
12.13.2 Representative OTC Drug Product
12.13.3 OTC Drug Sales, Revenue, Price and Gross Margin of Daiichi Sankyo
12.14 Friggs
12.14.1 Company profile
12.14.2 Representative OTC Drug Product
12.14.3 OTC Drug Sales, Revenue, Price and Gross Margin of Friggs
12.15 DSM
12.15.1 Company profile
12.15.2 Representative OTC Drug Product
12.15.3 OTC Drug Sales, Revenue, Price and Gross Margin of DSM
12.16 Eisai
12.17 Eli Lilly
12.18 Herbalife
12.19 Euradite
CHAPTER 13 UPSTREAM AND DOWNSTREAM MARKET ANALYSIS OF OTC DRUG
13.1 Industry Chain of OTC Drug
13.2 Upstream Market and Representative Companies Analysis
13.3 Downstream Market and Representative Companies Analysis
CHAPTER 14 COST AND GROSS MARGIN ANALYSIS OF OTC DRUG
14.1 Cost Structure Analysis of OTC Drug
14.2 Raw Materials Cost Analysis of OTC Drug
14.3 Labor Cost Analysis of OTC Drug
14.4 Manufacturing Expenses Analysis of OTC Drug
CHAPTER 15 REPORT CONCLUSION
CHAPTER 16 RESEARCH METHODOLOGY AND REFERENCE
16.1 Methodology/Research Approach
16.1.1 Research Programs/Design
16.1.2 Market Size Estimation
16.1.3 Market Breakdown and Data Triangulation
16.2 Data Source
16.2.1 Secondary Sources
16.2.2 Primary Sources
16.3 Reference
